Newsight Tech Angels
Overview
Newsight Tech Angels is an angel group based in Tokyo, Japan, that seeks to invest in the life sciences and financial industries sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TRIO Pharmaceuticals, Inc. | Mar 2023 | Seed | Co-investor |
| GigaMune | May 2023 | Pre Seed | Co-investor |
| Aptadel Therapeutics | Mar 2026 | VC Round | Lead |
| CrestecBio Inc. | Feb 2023 | Angel | Co-investor |
| Eyegenex Inc. | Sep 2023 | Pre Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Newsight Tech Angels based?
Newsight Tech Angels is headquartered in Tokyo, Japan.
When was Newsight Tech Angels founded?
Newsight Tech Angels was founded in 2022.
How many portfolio companies does Newsight Tech Angels have?
Newsight Tech Angels has 5 portfolio companies in Caplight's dataset.
What are some companies in Newsight Tech Angels's portfolio?
Portfolio companies visible on Caplight include TRIO Pharmaceuticals, Inc., GigaMune, Aptadel Therapeutics, CrestecBio Inc., Eyegenex Inc..
What was Newsight Tech Angels's most recent investment shown here?
Newsight Tech Angels's most recent investment in this portfolio sample was in Aptadel Therapeutics in 2026.
What sectors does Newsight Tech Angels focus on?
Newsight Tech Angels focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Newsight Tech Angels focus on?
Newsight Tech Angels typically invests at the Early stage.